Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | AYLA | PSTV | CANF | ||
Company | Ayala Pharmaceuticals Inc | Plus Therapeutics Inc | Can-Fite Biopharma Ltd ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
Open | 0.4876 | 1.3100 | 2.03 | ||
High | 0.5698 | 1.4599 | 2.08 | ||
Low | 0.4399 | 1.2894 | 1.91 | ||
Last | 0.5036 | 1.3100 | 1.95 | ||
Change | +0.0278 | -0.1500 | -0.06 | ||
% Change | +5.84% | -10.27% | -2.99% | ||
Volume | 137,700 | 147,700 | 70,100 | ||
20-Day Average Volume | 60,750 | 88,370 | 124,225 | ||
Previous Close | 0.4758 | 1.4600 | 2.01 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.4529 | 1.4870 | 2.17 | ||
20-Day Raw Stochastic | 62.79% | 20.75% | 13.24% | ||
20-Day Relative Strength | 47.42% | 42.91% | 37.26% | ||
Weighted Alpha | -90.06 | -25.05 | -52.70 | ||
Today's Opinion | 80% Sell | 96% Sell | 56% Sell | ||
Previous Opinion | 80% Sell | 88% Sell | 56% Sell | ||
Last Month's Opinion | 100% Sell | 100% Sell | 24% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -1.27% since 01/10/23 | -14.38% since 09/24/24 | -4.41% since 09/24/24 | ||
Low | 0.4399 on 01/18/23 | 1.2894 on 10/01/24 | 1.91 on 10/01/24 | ||
High | 0.5830 on 01/11/23 | 1.9400 on 09/27/24 | 2.08 on 09/26/24 | ||
1-Month | |||||
%Chg | +0.68% since 12/16/22 | -8.39% since 08/30/24 | -12.16% since 08/30/24 | ||
Low | 0.3568 on 01/03/23 | 1.1450 on 09/09/24 | 1.87 on 09/20/24 | ||
High | 0.5906 on 01/10/23 | 1.9400 on 09/27/24 | 2.50 on 09/13/24 | ||
3-Month | |||||
%Chg | -44.75% since 10/18/22 | -12.67% since 07/01/24 | -25.29% since 07/01/24 | ||
Low | 0.3568 on 01/03/23 | 1.1450 on 09/09/24 | 1.87 on 09/20/24 | ||
High | 0.9611 on 10/19/22 | 2.0700 on 07/17/24 | 4.69 on 07/22/24 | ||
6-Month | |||||
%Chg | -50.63% since 07/18/22 | -27.22% since 04/01/24 | -15.58% since 04/01/24 | ||
Low | 0.3568 on 01/03/23 | 1.1450 on 09/09/24 | 1.87 on 09/20/24 | ||
High | 2.4200 on 07/26/22 | 2.6702 on 06/05/24 | 4.69 on 07/22/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 7,464 | 8,328 | 7,116 | ||
Shares Outstanding, K | 14,821 | 5,704 | 3,540 | ||
Annual Sales | 3,510,000 | 4,910,000 | 740,000 | ||
Annual Net Income | -40,250,000 | -13,320,000 | -7,630,000 | ||
Last Quarter Sales | 90,000 | 1,280,000 | 160,000 | ||
Last Quarter Net Income | -10,190,000 | -2,940,000 | -1,650,000 | ||
60-Month Beta | 1.98 | 0.65 | 1.41 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.66 on 11/04/22 | -0.71 on 08/14/24 | -0.31 on 03/28/24 | ||
Latest Earnings Date | 11/21/22 | 10/29/24 | 10/03/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |